Probes for use in time-resolved fluorescence competitive binding assays at melanocortin receptors based on the parental ligands MSH(4), MSH (7), and NDP-a-MSH were prepared by solid phase synthesis methods, purified, and characterized. The saturation binding of these probes was studied using HEK-293 cells engineered to overexpress the human melanocortin 4 receptor (hMC4R) as well as the human cholecystokinin 2 receptor (hCCK2R). The ratios of non-specific binding to total binding approached unity at high concentrations for each probe. At low probe concentrations, receptor-mediated binding and uptake was discernable, and so probe concentrations were kept as low as possible in determining K d values. The Eu-DTPA-PEGO-MSH(4) probe exhibited low specific binding relative to non-specific binding, even at low nanomolar concentrations, and was deemed unsuitable for use in competition binding assays. The Eu-DTPA-PEGO probes based on MSH(7) and NDP-a-MSH exhibited K d values of 27 ± 3.9 nM and 4.2 ± 0.48 nM, respectively, for binding with hMC4R. These probes were employed in competitive binding assays to characterize the interactions of hMC4R with monovalent and divalent MSH(4), MSH(7), and NDP-a-MSH constructs derived from squalene. Results from assays with both probes reflected only statistical enhancements, suggesting improper ligand spacing on the squalene scaffold for the divalent constructs. The K i values from competitive binding assays that employed the MSH(7)-based probe were generally lower than the K i values obtained when the probe based on NDP-a-MSH was employed, which is consistent with the greater potency of the latter probe. The probe based on MSH(7) was also competed with monovalent, divalent, and trivalent MSH(4) constructs that previously demonstrated multivalent binding in competitive binding assays against a variant of the probe based on NDP-a-MSH. Results from these assays confirm multivalent binding, but suggest a more modest increase in avidity for these MSH(4) constructs than was previously reported.
Introduction
The affinity of a molecule for binding to a receptor is often quantified by a competitive binding assay against a labeled ligand of known potency. For example, labeled forms of Ac-Ser-Tyr-SerNle-Glu-His-DPhe-Arg-Trp-Gly-Lys-Pro-Val-NH 2 [NDP-a-MSH], a superpotent ligand that binds to melanocortin receptors, 1, 2 have been used for this purpose. 3, 4 In such assays, one often assumes thermodynamic control, i.e., that the respective on-rates and offrates of both the competing and competed ligands are similar so that all bound and unbound states are in equilibrium. If this is not the case, details of how the assay is carried out (order and timing of reagent addition, timing of measurements taken) can affect the outcome. Determination of on-rates and off-rates for binding of molecules to living cells is difficult since ligands and labeled 0968-0896/$ -see front matter Ó 2013 Elsevier Ltd. All rights reserved. http://dx.doi.org/10.1016/j.bmc.2013.06.052
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probes may be taken up by the cells and because receptors may cycle to and from the cell surface. In the absence of knowledge of ligand and probe on-rates and off-rates, a close match between the affinities of the competed probe and the competing ligand in a competitive binding assay would seem prudent-but is it necessary? This issue was examined experimentally as reported herein.
We have investigated the binding of multivalent molecules, including several derived from the weak ligand Ac-His-DPhe-ArgTrp-NH 2 [MSH(4)] [5] [6] [7] , to human melanocortin 4 receptors (hMC4R). 8 MSH (4) was selected because synergistic effects are generally more easily detected for multivalent constructs of low-affinity ligands. [9] [10] [11] [12] [13] Probe 1 is based on NDP-a-MSH and was used to determine the K i values for many of our multivalent constructs. However, we became concerned that competitions between superpotent probes such as 1 and multivalent constructs based on much weaker ligands such as MSH (4) were inherently unbalanced, and that perhaps the measured avidity of a competing multivalent construct depended on the affinity of the competed fluorescent probe. In a preliminary study, we prepared the Eu-DTPA-PEGO-MSH(4) probe 2 and tested it in saturation and competitive binding assays. 14 The K d of 2, determined by saturation binding to HEK-293 cells overexpressing hMC4R, was 9.1 lM, compared with a reported K d for 1 of 8.3 nM. 15 We report herein syntheses of the structurally related probes Eu-DTPA-PEGO-MSH(7) 3 and Eu-DTPA-PEGO-NDP-a-MSH 4, studies of the saturation binding of 2-4 with hMC4R, and the use of 3 and 4 in competitive binding assays involving monovalent and divalent MSH(4), MSH (7), and NDP-a-MSH constructs derived from squalene 16 , as well as monovalent, divalent, and trivalent MSH (4) constructs that previously exhibited multivalent binding in competitive binding assays against a variant of probe 4. 13 C NMR). Preparative HPLC was performed on a 19 Â 256 mm Waters X-Bridge Preparative C 18 column. The mobile phase was 10-90% acetonitrile and water containing 0.1% trifluoroacetic acid (TFA) within 50 min. The flow rate was 15 mL/min. The dual UV detector system operated at 230 and 280 nm. ESI experiments were performed on an ESI Bruker Apex Qh 9.4 T FT-ICR instrument using standard ESI conditions. The samples were dissolved in acetonitrile/water 1:1 containing 0.1% formic acid in a concentration range of 1-30 lM.
Solid phase synthesis
For the synthesis of probes 2-4, resin-bound MSH(4), MSH (7), and NDP-a-MSH were synthesized manually using an N a -Fmoc/tBu solid-phase peptide synthesis strategy and standard DIC/HOBt activation on Rink amide Tentagel S resin (approximately 0.24 mmol of active sites per gram). For the synthesis of ligands 5-7, 16, and 17, resin-bound MSH(4), MSH (7), and NDP-a-MSH were synthesized manually using an N a -Fmoc/t-Bu solid-phase peptide synthesis strategy and standard DIC/Cl-HOBt activation on Rink amide resin (approximately 0.68 mmol of active sites per gram) as follows. Resin (1.0 g) in a syringe (polypropylene reaction tube equipped with a polypropylene frit) was allowed to swell in THF for 1 h. THF was removed, and 20% piperidine in DMF (15 mL) was added to deprotect the Fmoc functionality. After 2 min, the DMF/piperidine solution was removed, 20% piperidine in DMF (15 mL) was again added, and the mixture was shaken for 18 min. The DMF/piperidine solution was removed and the resin washed with DMF (3 Â 15 mL), DCM (3 Â 15 mL), DMF (3 Â 15 mL), 0.5 M HOBt in DMF (1 Â 15 mL), 0.5 M HOBt in DMF (1 Â 15 mL) plus a drop of 0.01 M bromophenol blue in DMF, DMF (2 Â 15 mL), and DCM (1 Â 15 mL), in that order. For Rink amide resin, a mixture of the appropriate Fmoc-amino acid (3 equivalents), Cl-HOBt (3 equivalents), and DIC (6 equivalents) in DMF (15 mL) was allowed to react for 2 min, was then added to the resin, and the mixture shaken for 1 h, during which time the blue color disappeared. The resin was then washed with DMF (3 Â 15 mL), DCM (3 Â 15 mL), and DMF (3 Â 15 mL). Free NH 2 groups were capped by addition of a 1:1 mixture of acetic anhydride and pyridine (6 mL). After the mixture was shaken for 20 min, the resin was washed with DMF (3 Â 15 mL), DCM (3 Â 15 mL), and DMF (3 Â 15 mL). (7), and DTPA-PEGO-NDP-a-MSH constructs were purified by preparative HPLC and characterized by FT-ICR MS. The metal-free precursors were dissolved in 0.1 M ammonium acetate, the pH was adjusted to 8 with aqueous 0.1 M NH 4 OH, and 3 equiv of EuCl 3 6H 2 O in water were added. The reaction mixture was stirred at rt overnight. The excess EuCl 3 and ammonium salts were removed using a Sep-Pak Ò C 18 reverse-phase column with repetitive washing (20 mL of HPLC grade water). The final products 2-4 were eluted using 50% aqueous acetonitrile (4 mL), concentrated, lyophilized, and characterized by analytical HPLC and FT-ICR MS. Data appear in Table 1 .
2.1.2.2. Synthesis and characterization of azides 5-7. Azide 5 was prepared from the corresponding resin-bound tetrapeptide and 6-azidohexanoic acid as previously described. 20 Azides 6 and 7 were prepared in a manner similar to 5. Cleavage from the resin and deprotection were achieved using a cleavage mixture of trifluoroacetic acid, triisopropylsilane, thioanisole, and water (91:3:3:3). The mixture of cleavage cocktail and resin was shaken overnight, the solution was separated from the resin, volatiles were evaporated, the residue triturated with ether, and the crude product separated by centrifugation. Following purification by preparative HPLC, compounds 5-7 were characterized by ESI MS. Data appear in Table 1 . In a threenecked flask a solution of borane-tetrahydrofuran complex in THF (1 M, 132 mL, 132 mmol) was deoxygenated with argon gas. The flask was immersed in an ice bath, and 2-methyl-2-butene (2 M, 132 mL, 264 mmol) also deoxygenated with argon gas was added to the borane solution dropwise with stirring at 0°C. The resulting disiamyl borane was maintained at 0°C for 3 h prior to use. A solution of squalene (3.0 gm, 7.3 mmol) in THF was then added dropwise at 0°C. The mixture was stirred at 0°C for 5 h, kept at 4°C for 3 d, then 3 N NaOH (80 mL) and 30% H 2 O 2 (80 mL) were added. The reaction mixture was stirred at rt for 12 h and was then diluted with EtOAc (500 mL), washed with water (2 Â 200 mL), brine (2 Â 100 mL), dried (Na 2 SO 4 ), filtered, and concentrated in vacuo to leave a viscous oil. The oil was subjected to gravity column chromatography on silica gel 60 eluted with chloroform-methanol (95:5), giving 1.94 g (51%) of 8 as a white, foamy solid, mp 42-46°C, R f 0.3 (silica gel 60, 1:9 MeOH:CHCl 3 ). IR (neat) cm À1 3350 (br), 2956, 1464, 1376. NMR spectra are complex since the product is a mixture of regioisomers and stereoisomers. To a suspension of NaH (113 mg, 4.74 mmol) in DMF (10 mL) was added a solution of 8 (821 mg, 1.58 mmol) in DMF (5 mL) and the mixture was stirred at rt for 15 min. Tetrabutylammonium iodide (294 mg, 0.8 mmol) and a solution of 1-bromo-5-hexyne 21 (1.27 g, 7.90 mmol) in DMF (3 mL) were added to the reaction mixture and stirring was continued for 24 h. The mixture was then diluted with ether (150 mL), washed with water (3 Â 50 mL), brine (20 mL), dried (Na 2 SO 4 ), filtered, and concentrated in vacuo to give a pale yellow oil. The oil was subjected to gravity column chromatography on silica gel 60 eluted with 2% MeOH/CHCl 3 , giving 220 mg (21%) of bisalkyne 10 as a viscous gum, R f 0.7 (silica gel 60, 1:9 MeOH/CHCl 3 ). Further elution of the column with 5% MeOH/CHCl 3 gave 410 mg (43%) of monoalkyne 9, also as a viscous gum, R f 0.4 (silica gel 60, 1:9 MeOH/ CHCl 3 ). NMR spectra are complex since the products are mixtures of regioisomers and stereoisomers. 
Synthesis and characterization of 14b.
To a mixture of alkyne 10 (7.5 mg, 11 lmol), TBTA (3 mg, 6 lmol), and tetrakis(acetonitrile)copper(I) hexafluorophosphate (2 mg, 6 lmol) in dry methanol (1 mL) was added MSH(7) azide 6 (26 mg, 23 lmol). Triazole 16 was prepared from the corresponding resin-bound tetrapeptide as previously described. 20 Triazole 17 was prepared in a similar manner from the corresponding resin-bound heptapeptide. Following attachment of the N-terminal 6-(4-butyl-1H-1,2,3-triazol-1-yl)hexanoic acid residue, cleavage and deprotection were achieved using a 91:3:3:3 mixture of trifluoroacetic acid, triisopropylsilane, thioanisole, and water (10 mL). The mixture of cleavage cocktail and resin was shaken overnight, the solution was separated from the resin, volatiles were evaporated, the residue triturated with ether, and the crude product separated by centrifugation. of pre-diluted probes 2-4 were then added to the cell-containing plates and the plates were incubated at 37°C. After 1 h the media was removed and the plates were washed (3 Â 175 lL/well) using wash buffer (1L DMEM, 1 g BSA, 20 lM EDTA, 0.01% Tween20).
Enhancement solution (PerkinElmer 1244-105) was added (105 lL/well) and the plates were incubated for 30 min at 37°C before fluorescence was measured using a VICTOR TM X4 2030 Multilabel Reader (PerkinElmer) employing the standard Eu timeresolved fluorescence (TRF) measurement settings (340 nm excitation, 400 ls delay, and emission collection for 400 ls at 615 nm).
Competition Binding Assays.
Serial dilutions of compounds to be tested were made in different well plates in binding buffer (1L DMEM, 5.97 g Hepes, 0.2% BSA, 1 mM 1,10-phenanthroline, 0.5 mg/L leupeptin, 200 mg/L bacitracin, pH adjusted to 7.4 using 2 N NaOH, 50 lL total volume) before adding to plates containing cells. Stock solutions of Eu-labeled probes were diluted with binding buffer to a concentration of 40 nM for 3 and 10 nM for 4. Plates containing cells were removed from the incubator, media was removed and replaced with binding buffer containing the Eu-labeled probe (50 lL/well), the solutions of compounds to be tested (concentration range generally 10 À4 -10 À11 M) were added, and the plates incubated at 37°C. After 1 h the media was removed and the plates were washed (3 Â 175 lL/well) using wash buffer (1L DMEM, 1 g BSA, 20 lM EDTA, 0.01% Tween20). Enhancement solution (PerkinElmer 1244-105) was added (105 lL/well) and the plates were incubated for 30 min at 37°C before fluorescence was measured using using a VICTOR TM X4 2030 Multilabel
Reader (PerkinElmer) employing the standard Eu time-resolved fluorescence (TRF) measurement settings (340 nm excitation, 400 ls delay, and emission collection for 400 ls at 615 nm).
Data Analysis.
Binding data were analyzed using GraphPad Prism software. Saturation binding data were analyzed using nonlinear regression analysis and fitted to classic one site total binding and nonspecific binding equations. Results from saturation binding experiments are depicted in Figure 2 and given in Table 2 . The values of K d given represent averages of four independent saturation binding experiments, each consisting of four data points per concentration tested. Competitive binding data were analyzed using nonlinear regression analysis and fitted to a classic one site binding competition equation. Each IC 50 value was generated from individual competitive binding assays and converted to a K i value using the equation Table 3 . The values of K i given represent averages of four independent competition binding experiments, each consisting of four data points per concentration tested.
Results

Chemistry
Fully protected resin-bound precursors to probes 2-4 and azides 5-7 were prepared by solid phase synthesis on Rink amide Tentagel S resin (for probe synthesis) or on Rink amide resin (for ligand synthesis). For the preparation of probes 2-4, Fmoc-PEGO 18 was coupled to the N-terminus of the resin-bound peptides. Following removal of the Fmoc, DTPA, 19 activated as the HOBt ester, was attached to the N-terminus of the PEGO spacer. Simultaneous side chain deprotection and cleavage of the peptide from the resin produced the metal-free precursors to 2-4 which were purified by preparative HPLC and characterized by FT-ICR MS. Following complexation of Eu 3+ , the Eu-DTPA-PEGO probes 2-4 were purified by reversed phase chromatography and characterized by analytical HPLC and FT-ICR MS (Table 1) . For the preparation of azides 5-7, 6-azidohexanoic acid 22 was coupled to the N-terminus of the resin-bound peptides. Simultaneous side chain deprotection and cleavage of the peptide from the resin produced compounds 5-7 which were purified by reversed phase preparative HPLC and characterized by ESI MS (Table 1) . Yields ranged from 39-60%.
Reaction of squalene with excess disiamylborane, followed by oxidation, produced hexaol 8 in 51% yield as a white foam (Scheme 1). Analysis by 13 C NMR (Fig. 1) confirmed that hydroboration had been regioselective and had yielded a mixture of diastereomeric secondary alcohols as depicted in 8. 16, 20 Treatment of 8 with three equivalents of sodium hydride and five equivalents of 6-bromo-1-hexyne 21 in DMF gave a mixture of alkylation products from which monoalkynes 9 and dialkynes 10 were isolated in 21% and 43% yields, respectively, by silica gel column chromatography. It is assumed that 9 and 10 are mixtures of regioisomers due to random alkylation at oxygen atoms along the carbon backbone. Copper(I)-catalyzed azide-alkyne cycloaddition (CuAAC) reactions 23 of 9 and 10 with excesses of the serine amide-derived azide 11 20 gave the corresponding triazole-containing products 12a and 12b in 52% and 90% yields, respectively, following chromatographic purification (Scheme 1). These compounds were characterized by NMR and ESI MS. CuAAC reactions of 9 and 10 with excesses of azide 5 gave the corresponding triazoles 13a and 13b. Copper ions were removed from the crude product mixtures by complexation with dithizone and removal of the complex by extraction with CHCl 3 . 24 The water-soluble products 13a and 13b
were purified by preparative reversed phase HPLC, recovered by lyophilization in 18% and 53% yields, respectively, and characterized by ESI MS. In a similar manner, CuAAC reactions of 9 and 10 with excesses of azides 6 and 7 gave the corresponding triazolecontaining products 14a, 14b, 15a, and 15b in 24%, 40%, 58%, and 62% yields, respectively, after workup and purification (Scheme 1). These compounds were characterized by ESI MS. The synthesis and characterization of compound 16 was previously reported. 20 Compound 17 was prepared in a similar manner by N-terminal acylation of the resin-bound heptapeptide with 6-(4-butyl-1H-1,2,3-triazol-1-yl)hexanoic acid. 20 The synthesis and characterization of compounds 18-20 were previously reported. 17 
Bioassays
HEK-293 cells overexpressing both hMC4R 8, 25 and hCCK2R 26 were used to measure the affinities of probes 2-4 for binding to hMC4R by means of saturation binding assays (Fig. 2) . 15 K d values for probes 2-4 are given in Table 2 . Europium-based time-resolved fluorescence competitive binding assays using Eu-DTPA-PEGO-MSH(7) (3) and Eu-DTPA-PEGO-NDP-a-MSH-NH 2 (4) as the competed probes were employed to study the binding of monovalent and bivalent serinamide, MSH(4), MSH (7), and NDP-a-MSH constructs 12a-15a and 12b-15b. Competitive binding assays using probe 3 as the competed probe were employed to study the binding of monovalent, divalent, and trivalent MSH(4) constructs 18-20. 17 K i values for these compounds and for the control compounds 16, 17, and 7 are given in Table 3 .
Discussion
Previously we described the preparation and testing of scaffolds derived from squalene, 14, 16 solanesol, 20 and sucrose 27 with one or more sidechains bearing MSH(4), a ligand with a low micromolar affinity for binding to hMC4R. MSH(4) was chosen because synergistic effects are generally more easily detected for multivalent constructs of low-affinity ligands. [9] [10] [11] [12] [13] All of the monovalent and multivalent MSH(4) constructs derived from squalene, solanesol, and sucrose exhibited competitive binding to hMC4R that was comparable to the parental ligand. The competed probe used in these studies was Eu-DTPA-NDP-a-MSH (1), which is based on the superpotent ligand NDP-a-MSH. The off-rate of NDP-a-MSH is approximately eight hours. 28 In addition, evidence suggests that receptor-bound 1 is taken up by the cells. 29 For these reasons, it was clear that competition binding assays involving 1 and hMC4R on living cells do not take place under thermodynamic control. This fact raised the possibility that the competition for binding to hMC4R between 1 and any variant of MSH(4) was biased in favor of 1, to the detriment of multivalent binding. To determine what effects might result from the use of probes with a lesser affinity for hMC4R, the set of Eu-DTPA-PEGO probes 2-4 was prepared by standard solid phase methods. Saturation binding assays for 2-4 were carried out using HEK-293 cells that stably overexpress both hMC4R (6 Â 10 5 receptors per cell) and hCCK2R (1 Â 10 6 receptors per cell). 15 These cells were employed so that results obtained here will be comparable with results from studies with multimeric constructs that bear ligands targeted to hCCK2R and with multimeric constructs that bear mixtures of ligands targeted to both receptors. 30 In all cases, non-specific binding was determined by blocking binding to hMC4R with a high concentration of NDP-a-MSH. Although probe 2 exhibited 20% as much non-specific binding as did probes 3 and 4 (see Fig. 2 ), the difference between total binding and non-specific binding for 2 was small, even at very low concentrations of the probe. Thus, the measured K d has a large associated error (93 ± 100 nM), and plans to use probe 2 in competition binding assays were abandoned. 31 As with probe 2, graphs of total and non-specific binding for probes 3 and 4 appear to be linear and parallel at high concentrations (see Fig. 2 ), consistent with some form of receptor-independent binding and/or uptake as opposed to receptor saturation. However, at sufficiently low concentrations, the differences between total and non-specific binding for probes 3 and 4 were significant, and permitted the calculation of reasonable K d values (see Table 2 ) so that use of these probes in competition binding assays was deemed possible.
For competition assays, a range of ligand potencies attached to monovalent, bivalent, and trivalent constructs was desired. Azides 5-7 were prepared by standard solid phase methods. Scaffolds 9 and 10 were prepared from squalene via hexaol 8 as depicted in Scheme 1. 16 Attachment of azides 5-7 to 9 and 10 by means of microwave-assisted copper(I)-catalyzed azide-alkyne cycloaddition (CuAAC) 23 produced monovalent and bivalent constructs 13a and 13b incorporating MSH(4), 14a and 14b incorporating MSH (7), and 15a and 15b incorporating NDP-a-MSH. Control compounds 12a and 12b were prepared by CuAAC reaction of serine amide-derived azide 11 20 with 9 and 10. In addition, MSH(4)-containing compounds 18-20, which were recently shown to exhibit enhanced avidity with increased ligand number when competed against an NDP-a-MSH-based probe, 17 were here competed against MSH(7)-based probe 3. Compounds 16, 20 17, and 7 were used as reference compounds in place of the parental ligands.
Results of the competition binding assays are given in Table 3 . The serine amide-containing control compounds 12a and 12b were both ineffective at blocking probes 3 and 4 from binding to hMC4R Scheme 1. Synthesis of monovalent constructs 12a-15a and divalent constructs 12b-15b. Compounds 8, 9, and 10 were obtained as complex mixtures of stereoisomers and regioisomers. Compounds 12a-15a and 12b-15b, derived from 9 and 10, respectively, are likewise assumed to be the related mixtures of stereoisomers and regioisomers.
over the range of concentrations tested. For the squalene-derived monovalent and divalent constructs, the trends in K i values are consistent for all three ligands tested, MSH(4) (compare 16, 13a, and 13b), MSH(7) (compare 17, 14a, and 14b), and NDP-a-MSH (compare 7, 15a, and 15b). Squalene-derived monovalent compounds exhibit a higher K i value than the control, often a factor of two, presumably due to compromised ligand binding, while the corresponding divalent compound exhibits a lower K i value, often a factor of two that can be ascribed to statistical doubling of the number of ligands. In all but one case, the K i value obtained using probe 4 was higher than the corresponding K i value obtained using probe 3, a result that is consistent with the stronger binding of 4 versus 3 to hMC4R. In view of past results with monovalent and multivalent compounds derived from squalene, 14, 16 solanesol, 20 sucrose, 27 and compounds 18-20, 17 the results herein suggest that the MSH(4) ligands in compounds 13b-15b are spaced too far apart for manifestation of multivalent binding. Enhanced avidity interpretable as multivalent binding was observed when compounds 18-20 were competed against probe 3, although the lowering of the K i values with each additional ligand (approximately ninefold at each step) was attenuated when compared with K i values calculated from published EC 50 data for competition binding assays that employed a Eu-DTPA-PEGO-NDPa-MSH probe similar to 4 (approximately 16-fold and 22-fold, see Table 3 ). 17 Although different sets of data were produced, similar conclusions were reached from competition binding experiments that employed probes 3 and 4, regardless of the potency of the ligand being competed. Probe 3 requires less time and effort to prepare, and so may find favor over probe 4 in future competition binding studies. However, confirmation of observed binding behaviors by the use of both probes would seem a prudent practice.
